Odyssey Health (ODYY) Free Cash Flow Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Free Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 29.64% |
| Jan 31, 2026 | 1.78% |
| Oct 31, 2025 | 1.32% |
| Jul 31, 2025 | 31.02% |
| Apr 30, 2025 | 31.29% |
| Jan 31, 2025 | 14.06% |
| Oct 31, 2024 | -2.96% |
| Jul 31, 2024 | -2.33% |
| Apr 30, 2024 | -44.38% |
| Jan 31, 2024 | -374.83% |
| Oct 31, 2023 | -26.65% |
| Jul 31, 2023 | -19.09% |
| Apr 30, 2023 | -123.22% |
| Jan 31, 2023 | -71.25% |
| Oct 31, 2022 | -56.03% |
| Jul 31, 2022 | 98.90% |
| Apr 30, 2022 | -59.06% |
| Jan 31, 2022 | -92.22% |
| Oct 31, 2021 | -275.01% |
| Jul 31, 2021 | -137.59% |